Fujirebio Showcases Range of Novel Testing Solutions

Fujirebio (Tokyo, Japan) is showcasing its LUMIPULSE G series of chemiluminescent enzyme immunoassay (CLEIA) analyzers and kits for fully automated testing at MEDICA 2023. The LUMIPULSE G series includes the LUMIPULSE G1200 fully automated immunoassay instrument which uses a unique mono test cartridge concept. It has a true throughput of 120 tests per hour and provides outstanding flexibility and easy handling in hospitals and clinical laboratories.

Fujirebio is also highlighting the latest member of the LUMIPULSE G series, the LUMIPULSE G600II which is a compact and robust benchtop analyzer with a constant throughput of 60 tests per hour. The system uses a unique mono test cartridge concept (the same cartridge concept as the mid-sized LUMIPULSE G1200 analyzer) and offers outstanding flexibility and easy handling to hospitals and clinical laboratories. The easy-to-use analyzer provides a perfect fit in laboratories aiming for personalized workflow solutions without compromising testing quality. Fujirebio offers a number of kits for fully automated testing on the LUMIPULSE G series of CLEIA analyzers.

This includes Lumipulse G 25-OH Vitamin D is an immunoreaction cartridge for in vitro diagnostic (IVD) use for the quantitative determination of 25-hydroxyvitamin D (25-OH-D) in human serum or plasma to be used in the assessment of Vitamin D sufficiency. Fujirebio is highlighting the Lumipulse G Aldosterone immunoreaction cartridges for the quantitative measurement of aldosterone in human serum, plasma, or urine. Also being showcased at MEDICA 2023 is the Lumipulse G B•R•A•H•M•S PCT immunoreaction cartridges for IVD use with a two-step sandwich immunoassay method on the LUMIPULSE G system for the quantitative determination of procalcitonin (PCT) in human serum and plasma.

Related Links:
Fujirebio